Angela Middleton
Payments from drug & device makers
Across 203 payments — averaging $19.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$733
- AbbVie$290
- Pfizer$290
- Jazz Pharmaceuticals Inc.$225
- Biohaven Pharmaceutical Holding Company Ltd.$210
- SK Life Science, Inc.$194
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,87098%
- Education$992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 33 | $733 |
| AbbVie | 14 | $290 |
| Pfizer | 21 | $290 |
| Jazz Pharmaceuticals Inc. | 7 | $225 |
| Biohaven Pharmaceutical Holding Company Ltd. | 14 | $210 |
| SK Life Science, Inc. | 8 | $194 |
| Acadia Pharmaceuticals Inc | 7 | $154 |
| UCB, Inc. | 11 | $151 |
| AstraZeneca(2 entities) | 7 | $145 |
| Argenx US, Inc. | 7 | $143 |
| Harmony Biosciences LLC | 5 | $141 |
| Genentech USA, Inc. | 8 | $141 |
| Merz Pharmaceuticals, LLC | 5 | $132 |
| Lundbeck LLC | 7 | $121 |
| Amneal Pharmaceuticals LLC | 7 | $120 |
| Amgen | 5 | $93 |
| Neurocrine Biosciences, Inc. | 4 | $80 |
| TG Therapeutics, Inc. | 3 | $72 |
| EMD Serono, Inc. | 4 | $66 |
| Biogen | 3 | $64 |
| Lilly USA, LLC | 4 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Johnson & Johnson | 2 | $27 |
| Livanova USA, Inc. | 1 | $25 |
| Amylyx Pharmaceuticals, Inc. | 1 | $21 |
| GE HealthCare | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Corium, LLC | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Piramal Critical Care | 1 | $18 |
| Impel Pharmaceuticals Inc. | 1 | $18 |
| Eisai Inc. | 1 | $17 |
| Cala Health, Inc. | 1 | $17 |
| Bristol Myers Squibb | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
| Avanir Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,969 in reported general payments places this provider in the 90th percentile of 3,812 family providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 25 | $697 |
| Topiramate | 15 | $118 |
Paid to pharmacies, not to this prescriber.
Other family in Rolla
- Connie SpencerSaint Joseph$320K
- Shayla SandersKansas City$306K
- Tamera WolfLees Summit$215K
- Tiffany ArnoldFestus$177K
- Tiffany NelsonSedalia$164K
- Chelsey BeckerSaint Peters$104K
- Carey PattonDes Peres$94K
- Marcy MarkesColumbia$92K
- Laura HedigerSpringfield$71K
- Rebecca SeabaughSaint Louis$68K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.